Lantheus Holdings Overview

  • Year Founded
  • 1956

Year Founded

  • Status
  • Public

  • Employees
  • 1,193

Employees

  • Stock Symbol
  • LNTH

Stock Symbol

  • Investments
  • 12

  • Share Price
  • $102.09
  • (As of Friday Closing)

Lantheus Holdings General Information

Description

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Contact Information

Formerly Known As
Bristol-Myers Squibb Medical Imaging, New England Nuclear, Lantheus Mi Holdings
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 201 Burlington Road
  • South Building
  • Bedford, MA 01730
  • United States
+1 (800)
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 201 Burlington Road
  • South Building
  • Bedford, MA 01730
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lantheus Holdings Stock Performance

As of 20-Nov-2026, Lantheus Holdings’s stock price is $102.09. Its current market cap is $6.68B with 65.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$102.09 $102.10 $53.38 - $111.86 $6.68B 65.4M 1.02M $4.14

Lantheus Holdings Financials Summary

As of 30-Sep-2026, Lantheus Holdings has a trailing 12-month revenue of $1.56B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 6,530,957 4,650,480 5,972,726 4,247,892
Revenue 1,562,212 1,541,609 1,533,910 1,296,429
EBITDA 431,713 379,750 478,008 470,924
Net Income 269,905 233,559 312,442 326,661
Total Assets 2,456,133 2,227,399 1,980,340 1,651,149
Total Debt 624,283 619,432 619,438 616,946
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lantheus Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lantheus Holdings‘s full profile, request access.

Request a free trial

Lantheus Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follo
Other Devices and Supplies
Bedford, MA
1,193 As of 2025

Chicago, IL
 

Villepinte, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lantheus Holdings Competitors (8)

One of Lantheus Holdings’s 8 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GE HealthCare Technologies Corporation Chicago, IL
Guerbet Group Corporation Villepinte, France
Bruker Formerly VC-backed Billerica, MA
Boston Scientific Corporation Marlborough, MA
Bio-Rad Laboratories Corporation Hercules, CA
You’re viewing 5 of 8 competitors. Get the full list »

Lantheus Holdings Patents

Lantheus Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025213026-A1 Astatine-211-labelled psma-binding compounds Pending 04-Apr-2024
WO-2025038414-A1 Therapeutic methods of use of gas bubble compositions Inactive 16-Aug-2023
AU-2023217725-A1 Gas nano/micro-bubble compositions and uses thereof Inactive 09-Feb-2022
EP-4475899-A1 Gas nano/micro-bubble compositions and uses thereof Pending 09-Feb-2022
EP-4475899-A4 Gas nano/micro-bubble compositions and uses thereof Pending 09-Feb-2022 A61K49/223
To view Lantheus Holdings’s complete patent history, request access »

Lantheus Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lantheus Holdings Investments & Acquisitions (12)

Lantheus Holdings’s most recent deal was a PIPE with Radiopharm Theranostics for . The deal was made on 04-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Radiopharm Theranostics 04-Dec-2025 PIPE Drug Discovery
Life Molecular Imaging 21-Jul-2025 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Evergreen Theragnostics 01-Apr-2025 Merger/Acquisition BPO/Outsource Services
Radiopharm Theranostics 09-Jan-2025 PIPE Drug Discovery
Radiopharm Theranostics 22-Dec-2024 PIPE Drug Discovery
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Lantheus Holdings ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

29.19 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Lantheus Holdings’s complete esg history, request access »

Lantheus Holdings Affiliates

Subsidiaries (7)

Name Industry Location Year Founded
Evergreen Theragnostics Springfield, NJ 2019
Meilleur Technologies Dublin, OH 2018
Lantheus Cerveau Bedford, MA 2016
Life Molecular Imaging Berlin, Germany 2012
Lantheus Medical Imaging Retirement Savings Plan North Billerica, MA 2008
You’re viewing 5 of 7 affiliates. Get the full list.  »

Lantheus Holdings FAQs

  • When was Lantheus Holdings founded?

    Lantheus Holdings was founded in 1956.

  • Where is Lantheus Holdings headquartered?

    Lantheus Holdings is headquartered in Bedford, MA.

  • What is the size of Lantheus Holdings?

    Lantheus Holdings has 1,193 total employees.

  • What industry is Lantheus Holdings in?

    Lantheus Holdings’s primary industry is Other Devices and Supplies.

  • Is Lantheus Holdings a private or public company?

    Lantheus Holdings is a Public company.

  • What is Lantheus Holdings’s stock symbol?

    The ticker symbol for Lantheus Holdings is LNTH.

  • What is the current stock price of Lantheus Holdings?

    As of 20-Nov-2026 the stock price of Lantheus Holdings is $102.09.

  • What is the current market cap of Lantheus Holdings?

    The current market capitalization of Lantheus Holdings is $6.68B.

  • What is Lantheus Holdings’s current revenue?

    The trailing twelve month revenue for Lantheus Holdings is $1.56B.

  • Who are Lantheus Holdings’s competitors?

    GE HealthCare Technologies, Guerbet Group, Bruker, Boston Scientific, and Bio-Rad Laboratories are some of the 8 competitors of Lantheus Holdings.

  • What is Lantheus Holdings’s annual earnings per share (EPS)?

    Lantheus Holdings’s EPS for 12 months was $4.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process